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Abstract
Background: Elephant endotheliotropic herpesviruses (EEHV) can cause an acute highly fatal hemorrhagic disease
in young Asian elephants (Elephas maximus), both ex situ and in situ. Amongst eight EEHV types described so far,
type 1 (subtype 1A and 1B) is the predominant disease-associated type. Little is known about routes of infection
and pathogenesis of EEHV, and knowledge of disease prevalence, especially in range countries, is limited.
Methods: A large cross-sectional serological survey was conducted in captive elephants (n = 994) throughout
Thailand using an EEHV-1A glycoprotein B protein antigen specific antibody ELISA.
Results: Antibody seroprevalence was 42.3%, with 420 of 994 elephants testing positive. Associations between
seropositivity and potential risk factors for EEHV infection were assessed and included: elephant age, sex, camp
cluster size, management type (extensive versus intensive), sampling period (wet vs. dry season) and location of
camp (region). Univariable regression analysis identified management system and region as risk factors for the
presence of EEHV antibodies in elephants, with region being significant in the final multivariable regression model.
Prevalence was highest in the North region of the country (49.4%).
Conclusions: This study produced baseline serological data for captive elephants throughout Thailand, and showed
a significant EEHV burden likely to be maintained in the captive population.
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Background
A number of infectious diseases significantly impact
elephant population sustainability, particularly in captiv-
ity [1]. Of great concern over the past two decades is in-
fection with the elephant endotheliotropic herpesvirus
(EEHV), which can cause hemorrhagic disease (HD).
First recognized in 1999 [2], eight genetically-distinct
subtypes have been identified, at least six of which are
associated with high mortality [3]. In Asian elephants,
EEHV-1 (subtypes 1A and 1B) is the most common and
virulent, while EEHV-3, − 4 and − 5 are infectious, but
rarely fatal [4–7]. Hemorrhagic disease primarily affects
Asian elephants under 10 years of age, particularly those
between 1 and 4 years, as well as African elephants [8].
Onset of EEHV-HD is rapid, often with few early clinical
signs, resulting in death within a few hours to days after
presentation of the first clinical signs in ~ 80% of cases
that present with the disease [9]. Clinical signs are ini-
tially nonspecific, but can include lethargy, lameness and
colic, later progressing to include swelling of the head
and thoracic limbs, oral ulceration, and cyanosis of the
tongue as widespread endothelial cell necrosis occurs
[10]. Since its discovery, EEHV has been the cause of
60% of deaths of young captive-born Asian elephants in
western zoos, affecting almost one in four Asian
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elephant calves born in zoos globally [9]. EEHV is not
only present in ex situ collections, but has been
observed in situ in India [11], Thailand [6], Laos [12],
Cambodia, Myanmar, Nepal and Sumatra [3]. Overall,
more than 100 deaths from EEHV have been confirmed
globally [3, 13], with many more cases likely going
undiagnosed.
In Thailand, an earlier study sampled pharyngeal
lymph nodes and found no evidence of EEHV in 31
Asian elephants based on PCR [14]. More recently,
EEHV infection was confirmed in 15 cases using a
semi-nested PCR technique, of which 72% was
EEHV-1A [15]. Today, EEHV-1A is considered the
major threat among young Thai elephants [16], even
though not all elephants infected with EEHV develop
symptoms. For example, in Thailand, EEHV-1A was de-
tected in 29 healthy Asian elephants from trunk swab
samples [17]. Likewise, positive EEHV results have also
been reported for healthy elephants in western zoos [18,
19]. Therefore, it is now recommended that all elephant
calves between 1 and 8 years be screened weekly using
real time quantitative PCR (qPCR) to monitor viral loads
and numbers of monocytes and platelets [18–22]. Ele-
phants with a high viral load and low monocyte and/or
platelet counts should be treated immediately with anti-
viral and antibacterial drugs, as well as with supportive
agents to maintain circulatory homeostasis, prevent
inflammation which can lead to vascular shock (fluid
therapy, plasma transfusion, glucocorticosteroids), and
manage pain (NSAID’s) [22]. Unfortunately the efficacy
of medications is not only inconsistent, but has yet to be
clearly documented. A vaccine against EEHV is not
available yet. Although routine testing using qPCR is
generally done in a handful of western zoos, testing can
be problematic in range countries because of high costs,
and limited equipment and expertise. Despite progress
made in viral screening by PCR, especially for symptom-
atic animals, little is known about the pathogenesis and
transmission of this disease or about numbers of
elephants exposed or infected. Thus, the current lack of
sero-epidemiological data presents a significant gap in
knowledge of the EEHV disease burden and susceptibil-
ity in a species of commercial and cultural importance
to Thailand.
Determination of EEHV antibody titers to establish
seroprevalence rates among various elephant popula-
tions is based on detection of antibodies against an
EEHV-1A viral envelope protein, glycoprotein B (gB).
Screening of Asian elephants in U.S. and European zoos
showed that nearly 80% of PCR positive animals were
seropositive for this protein [23]. The aim of the present
study was to assess EEHV seroprevalence in a large
cross-sectional survey of elephants in Thailand using the
EEHV-1A gB protein antigen ELISA [23], and to obtain
preliminary data on factors potentially associated with
infection throughout the captive population in Thailand.
Materials and methods
Animals
The serological survey was conducted retrospectively on
serum samples collected between January 2010–February
2015, and comprised elephants (n = 994) in private,
tourist, and logging camps that were included in a health
screening program under the Mobile Elephant Clinic Pro-
ject in Thailand, led by trained veterinarians and staff of
the National Elephant Institute (NEI), Lampang, Thailand.
Animals tested represented ~ 25% of the total population
of captive elephants in the country. Only elephants
deemed healthy (asymptomatic) by veterinarians during
the routine examinations were included in this study.
Data and sample collection
Elephant information recorded consisted of owner name,
elephant name, sex, age, microchip number, copy of offi-
cial registration identity card, present address and health
information. Study variables are described in Table 1.
Male and female elephants were categorized into three
age groups: < 11 years; 11–50 years; and > 50 years.
Camps were divided into two types of management sys-
tems: intensive and extensive, as defined by Mar [24].
With intensive systems, elephants are managed individu-
ally or in small groups, are fed entirely by humans
through prepared fodder, and are tethered at night. They
may participate in work activities, such as trekking, but
often in a more urban setting. Extensive management in-
volves more traditional activities, like logging, forest
trekking, and bathing, and releasing elephants into the
forest by long chains or hobbles at night to forage and
potentially interact with other captive conspecifics.
Camps were grouped into six geographical regions, and
whether they were close to the border with neighbor
countries. Camps, within a radius of 2 km, that shared
resources like a river, road, land area, or working area
during the day were clustered and categorized based on
the number of elephants: small (< 10 elephants/cluster),
medium (10–50 elephants) and large (> 50 elephants).
Over the 5-year survey, elephants were sampled
throughout the year, with data grouped according to wet
(April–October) and dry (November–March) seasons in
Thailand.
A 5- to 7-ml blood sample was collected from an aur-
icular vein. Samples were transferred to blood collection
tubes and kept at room temperature for 1–2 h before
centrifugation to harvest serum. Serum samples were
stored frozen (− 20 °C) at the laboratory research unit of
the NEI until analysis. One blood sample per elephant
was used for this cross-sectional study, and randomly
selected when multiple samples were available. Serum
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samples were thawed, diluted 1:100 and 1:200 in
phosphate-buffered saline, and assessed for the presence
of antibodies using the EEHV gB specific capture ELISA
described by [23]. Results were expressed as OD ratios
(OD sample/OD background) for both serum dilutions
(1:100 and 1:200).
Statistical analysis
A single serum dilution (1:100 and 1:200) was consid-
ered positive when the OD ratio was ≥ 3, undetectable
at < 2, and inconclusive between 2 and 3 [23]. An animal
was deemed seropositive when one or both of the serum
dilutions were scored as positive. Results of univariable
logistic regression analyses of the potential risk factors
[elephant age, sex, camp cluster size, management type
(extensive versus intensive), sampling period (wet vs. dry
season) and location of camp (region) for the likelihood of
an EEHV positive sample were expressed as the OR, CI
and P-value. All potential risk factors were included in
multivariable logistic regression analysis to create the
model, with the exception of management type due to a
high correlation with region. Region was chosen to be in-
cluded in the full model because the model fit was better
than the full model with management type. The AIC was
used in a backward procedure to select the best model
(smaller AIC is better). All analyses were performed using
R version 3.3.0; 2016-5-3 [25].
Results
Descriptive analysis
Animals were housed at 96 camps in 20 provinces
throughout Thailand (Fig. 1); however, it was not
possible to sample all elephants at every camp because
elephants often were working or otherwise not available
when visited by the veterinarian. We sampled one to 57
elephants per camp: at 48 camps, five or more elephants
were sampled; at 25 camps, two to four elephants were
sampled, and at 23 camps, only a single elephant was
sampled. The interval between the first and last sam-
pling date within each camp varied from 0 to > 500 days,
although for 60 of the 96 camps (including 23 single
sample locations), sampling was done within an interval
of 30 days. Due to these limitations we cannot qualify
any camp as (fully) EEHV-negative or EEHV-positive.
Additional file 1: Figure S1 established from the present
test results, using OD ratio > 3 respectively OD ratio > 4
as cut offs! gives an impression of the proportions of
positive and negative animals).
Study population demographics are presented in Table 1.
Amongst the 994 elephants sampled, two-thirds were
female. The average age of the total population was
33.1 years (median = 34.0), with females averaging 33.8
(sd = 14.3; range, 2–76) years, and males averaging
28.9 (sd = 14.8; range, 3–66) years. The majority
(80.2%) of elephants were within the adult age
category (11–50 years), with 7.3% in the < 11 years
and 12.5% in the > 50 years age categories. The aver-
age number of elephants sampled per camp was 10.2
(sd = 13.3; range, 1–57), and per province was 49.7
(sd = 71.6; range, 1–286). Elephants were fairly equally
distributed between the two types of management
systems (Table 1), with most extensive-managed
camps located in the North region (86.1%). By
contrast, intensive management systems were found
in all regions except the North (Table 2). Most
elephants resided in large, clustered areas (60.7%), as
compared to small (1.9%) and medium (37.4%)
Table 1 Study population demographics, and potential risk
factors in association with EEHV antibody seroprevalence of
elephants in Thailand (n = 994)
Risk factors Category Number (proportion
male/female)
Sex Female 678 (0.68)
Male 316 (0.32)
Age category < 11 years 73 (0.45/0.55)
11–50 years 797 (0.30/0.70)
> 50 years 124 (0.29/0.71)
Management
type (province1)
Extensive:
(CM, LP, CR, SKT, Tak, CP)
505 (0.34/0.66)
(n = 286, 125, 8, 16, 68
and 2 respectively)
Intensive:
(AY, NKPT, RBR, PJ, CBR,
Trat, BRR, NKSM, SR, SRTN,
PNG, Smui, SKL, CPo)
489 (0.29/0.71)
(n = 76, 27, 36, 1, 166, 41,
1, 3, 56, 15, 63, 2, 1 and
1 respectively)
Region Central 76 (0.25/0.75)
East 207 (0.16/0.84)
North 435 (0.36/0.64)
Northeast 62 (0.50/0.50)
South 82 (0.46/0.54)
West 132 (0.25/0.75)
Camp cluster2 Small cluster
(< 10 elephants)
19 (0.20/0.80)
Medium cluster
(10–50 elephants)
372 (0.30/0.70)
Large cluster
(> 50 elephants)
603 (0.32/0.68)
Border contact
with Myanmar
Yes 77 (0.19/0.81)
No 917 (0.32/0.68)
Sampling
period
(months)
April–October 824 (0.30/0.70)
November–March 170 (0.38/0.62)
1CM = Chiang Mai, LP = Lampang, CR = Chiangrai, SKT = Sukhothai, Tak = Tak,
CP=Chaiyapum, AY = Ayuttaya, NKPT = Nakhonpathom, RBR = Ratchburi,
PJ = Prajuobkirikhan, CBR = Chonburi, Trat = Trat, BRR = Burirum, NKSM =
Nakhoratchsima, SR = Surinth, SRTN = Suratthani, PNG = Phang-nga,
Smui = Smui, SKL = Songkla and CPo = Chumporn
2Defined as number of camps (i.e., those within a radius of 2 km) that shared
resources like a river, road or land area, or working area during the day
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clusters (Table 2). Less than 10% of the study subjects
lived along the border with Myanmar in the West
and North regions (Table 1). The majority of samples
were collected during the wet season (April–October,
82.9%) (Table 1).
Prevalence
Serology results for both serum dilutions are shown in
Additional file 2: Table S1. A summary of serology re-
sults for separate analyses of 1:100 and 1:200 dilutions is
shown in Table 3. Of the samples designated as positive
using a 1:100 dilution, ~ 88% were also positive at 1:200.
Inconclusive results were similar between the 1:100 and
1:200 dilutions (287 versus 281), respectively, whereas
for the undetectable group, the 1:100 dilution identified
407 samples, of which only 285 remained undetectable
at 1:200. Eighteen undetectable samples at 1:100 became
positive at 1:200, as did 102 inconclusive samples. Based
on the criteria that a sample was considered positive if
at least one serum dilution was positive, 42.3% were
seropositive (420 of 994), 57.7% were undetectable (574
of 994) and none were inconclusive (Table 3).
Risk factor analysis
Descriptive serology test results related to potential risk
factors (Table 4) were used in the univariable logistic
regression analysis (Table 5). Variables used for the mod-
eling were elephant age, sex, camp cluster size, manage-
ment type (extensive versus intensive), sampling period
(wet vs. dry season) and location of camp (region).
Fig. 1 Locations of camps or clusters of camps with captive elephants (N = 994) enrolled in the present study are indicated with red dots. Red
dots marked with a black dot indicate sites that had at least one EEHV antibody seropositive elephant
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Border contact samples were unevenly distributed and
applied to only two regions (North and West), so those
data were not included in the univariable model. Female
elephants trended towards being less often seropositive
than males (OR = 1.29; p = 0.06), but there were no dif-
ferences between the age groups. Elephants from camps
utilizing extensive management systems had higher
seroprevalence than those managed more intensively,
with some regional differences. Compared to the North,
elephants in the Central, Northeast and East regions had
a lower odds for a positive sample. No association was
found for the EEHV status of the sample with camp
cluster size and sampling period.
In the multivariable logistic regression analysis, only
region remained in the model after backward elimination
of the variables and therefore the results are the same as
from the univariable model with region (Table 5).
Discussion
The present study was the first to conduct a large
cross-sectional survey of EEHV seroprevalence among
captive elephants in Thailand. Using an EEHV-1A gB
protein antigen ELISA [23], over 40% of elephants tested
were found to be seropositive. Although animals were
healthy at the time of blood collection, a significant
number appeared to have been exposed to EEHV based
on antibody seroprevelance, most likely maintaining this
virus within the population. Because it was not possible
to sample every elephant at each camp, we could not
determine if there were any 100% seropositive or sero-
negative camps in Thailand. However, the vast majority
Table 3 Comparison of antibody seroprevalence based on an
EEHV1A glycoprotein B protein antigen specific ELISA of
elephants sampled throughout Thailand between 2010 and
2015 (n = 994) using serum dilutions of 1:100 and 1:200
Dilution 1:100 Dilution 1:200
Positive1 Inconclusive2 Undetectable3 Totals (1:100)
Positivea 263 (*) 37 (*) 0 300
(87.7%) (12.3%) (0%)
Inconclusiveb 102 (*) 140 45 287
(35.5%) (48.8%) (15.7%)
Undetectablec 18 (*) 104 285 407
(4.4%) (25.6%) (70%)
Totals (1:200) 383 281 330 994
aOptical density (OD) ratio (OD sample/OD background) > 3
bOD ratio between 2 and 3
cOD ratio < 2
*At least one sample dilution was positive
Table 4 Antibody seroprevalence of elephants throughout
Thailand (n = 994) between 2010 and 2015 based on an EEHV1A
glycoprotein B protein antigen specific ELISA, and the
proportion of samples testing positive or negative relative to
potential EEHV risk factors
Potential risk factors Positivea Negative
Sex
Female (n = 678) 273 (40.2%) 405 (59.7%)
Male (n = 316) 147 (46.5%) 169 (53.4%)
Age category
< 11 years (n = 73) 32 (43.8%) 41 (56.2%)
11–50 years (n = 797) 331 (41.5%) 466 (58.5%)
> 50 years (n = 124) 57 (45.9%) 67 (54.0%)
Management type
Extensive (n = 505) 238 (47.1%) 267 (52.9%)
Intensive (n = 489) 182 (37.2%) 307 (62.8%)
Region
Central (n = 76) 17 (22.4%) 59 (77.6%)
East (n = 207) 78 (37.7%) 129 (62.3%)
North (n = 435) 215 (49.4%) 220 (50.6%)
Northeast (n = 62) 21 (33.9%) 41 (66.1%)
South (n = 82) 36 (43.9%) 46 (56.1%)
West (n = 132) 53 (40.2%) 79 (59.8%)
Camp clusterb
< 10 (n = 19) 11 (57.9%) 8 (42.1%)
10–50 (n = 372) 164 (44%) 208 (55.9%)
> 50 (n = 603) 245 (40.6%) 358 (59.4%)
Border contact
Yes (n = 77) 25 (32.5%) 52 (67.5%)
No (n = 917) 395 (43.0%) 522 (57.0%)
Evaluation period
Apr-Oct (n = 824) 337 (40.9%) 487 (59%)
Nov-Mar (n = 179) 83 (48.8%) 87 (51.2%)
aSamples were considered positive if at least one dilution (1:100, 1:200) was
positive (OD ratio > 3) . All other combinations were defined as negative
bDefined as number of camps (i.e., those within a radius of 2 km) that shared
resources like a river, road or land area, or working area during the day
Table 2 Numbers of elephants sampled in intensive and
extensive management systems within six geographical regions
in Thailand
Region Management System
Extensivea Intensiveb
Central 0 76
East 0 207
North 435 0
Northeast 2 60
South 0 82
West 68 64
aElephants are managed using more traditional methods, including daily
species-specific activities, and releasing elephants into the forest (by long
chains or hobbles) at night to forage and interact with tame and/or wild
conspecifics (U Mar, 2006)
bElephants are managed individually or in small groups, are fed entirely by
humans through prepared fodder, and are tethered at night (U Mar, 2006)
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of seronegative elephants resided at camps with
seropositive ones and so could be susceptible to infec-
tion in the future. In the study of van den Doel [23],
some elephants maintained significant titers for pro-
longed periods, while others were intermittently
seropositive. One seropositive elephant was categorized
as healthy at the time of blood collection, but had pre-
sented with EEHV-like symptoms a few weeks before.
This finding may indicate a prior EEHV infection, but
that could not be confirmed. Results suggest that routine
serological surveys may help identify prior viral expos-
ure, which would otherwise go undetected as many
exposed elephants are asymptomatic.
One of the characteristics of herpes viruses is their
ability to go into latency. By certain unknown stimuli
these latent viruses may be reactivated [26]. If reactiva-
tion does not occur over a long period of time, anti-
bodies may drop to levels near to or below the detection
limit of the ELISA. This makes it difficult to conclude
that inconclusive or seronegative elephants are actually
free of EEHV. The elephants in this study were all over
1 year of age, so maternal antibodies were not likely
present to influence the outcome of the ELISA. As there
is no vaccine against EEHV available, all antibody titers
that were detected are assumed to be the result of previ-
ous exposure to EEHV. Each elephant with antibodies
against EEHV should be considered as latently infected
and a potential periodical shedder [26, 27]. Camps that
consist of only seronegative animals are at risk of infec-
tion if a seropositive elephant is added to that camp;
however, a false seronegative status may be the result of
the absence of virus reactivation over a prolonged
period, or insensitivity of the ELISA to detect a signifi-
cant titer. As a consequence animals newly introduced
into a camp are at risk of infection depending on the
presence of even only one animal classified as EEHV in-
fected. Model building initiated by submitting sex, age,
regions, camp cluster size and sampling period (without
management type) to multivariable analyses gave rise to
the final multiple logistic regression model that identi-
fied “regions” as the most potent risk factor to EEHV in
Thailand. More specifically, our study revealed that the
Central, Northeast, East, West and South regions were
lower in prevalence compared to the North. This result
confirmed a higher incidence of EEHV in northern
regions [28] based on sample tissue submissions and
reported elephant deaths. Specifically, between 2006 and
2017, 32 clinical cases of EEHV-HD in Thailand were
confirmed by PCR techniques, and of those, a third
(n = 11) were found in the North. Overall, two thirds
of EEHV antibody seropositive elephants were found
in North, South and West regions of Thailand. By
contrast, only two cases (2/32) occurred in the
Central region, an area with only a few facilities close
together, with limited exchange of animals from the
outside. Understanding spatial differences in sero-
prevalence is complicated, however, by uncontrolled/
unregistered elephant movements and transfers,
particularly among facilities within those regions, and
so needs further study.
The type of elephant management system was a
significant risk factor to positive EEHV antibody sero-
prevalence in the univariable model, with 47% antibody
seroprevalence in extensive systems compared to 37% in
more intensive systems. The North and West regions
include areas along the border with Myanmar, and
contain more than half of the captive elephant popula-
tion in Thailand. Although there is clinical evidence of
EEHV-HD in captive elephants in Myanmar, there has
been no molecular confirmation to date (Charernpan P.,
personal communication, National Elephant Health
Service, DLD Thailand, 2017). However, given the close
Table 5 Univariable regression analysis of potential risk factors
for the presence of EEHV antibodies in elephants sampled
throughout Thailand between 2010 and 2015 (n = 994) based
on an EEHV1A glycoprotein B protein antigen specific ELISA
Potential risk factors Prevalence (%) p-Value OR 95% CI
Sex
Female (n = 678) 40.2 Ref 1 NA
Male (n = 316) 46.5 0.06 1.29 0.98–1.68
Age category (year)
< 10 (n = 73) 43.8 Ref 1 NA
10–50 (n = 797) 41.5 0.70 0.91 0.56–1.48
> 50 (n = 124) 45.9 0.77 1.09 0.61–1.95
Management type
Extensive (n = 505) 47.1 Ref 1 NA
Intensive (n = 489) 37.2 0.00 0.66 0.51–0.85
Region
North (n = 435) 49.4 Ref 1 NA
Central (n = 76) 22.4 < 0.00 0.29 0.16–0.51
East (n = 207) 37.7 0.00 0.61 0.44–0.86
Northeast (n = 62) 33.9 0.02 0.52 0.29–0.90
South (n = 82) 43.9 0.36 0.80 0.49–1.28
West (n = 132) 40.2 0.06 0.68 0.46–1.01
Camp clustera
< 10 (n = 19) 57.9 Ref 1 NA
10–50 (n = 372) 44.0 0.24 0.57 0.21–1.44
> 50 (n = 603) 40.6 0.13 0.49 0.19–1.24
Evaluation period
Apr-Oct (n = 824) 40.9 Ref 1 NA
Nov-Mar (n = 170) 48.8 0.37 1.24 0.76–2.01
Ref reference category, NA not applicable, OR odds ratio, CI confidence interval
aDefined as number of camps (i.e., those within a radius of 2 km) that shared
resources like a river, road or land area, or working area during the day
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contact and/or transport of captive elephants between
the Thai-Myanmar borders, transmission of the viral
disease to elephants in the North and West of Thailand
from Myanmar is possible, similar to what has been doc-
umented for foot and mouth disease viral transmission
across these regions [29, 30]. Captive elephants in
Myanmar are maintained in more natural habitats
(extensive care system), particularly at night. Most are
allowed to forage in nearby forests while on long chains,
so there is potential for more interaction between wild
and captive elephants in that country, whereas in
Thailand, captive and wild elephants are found to coha-
bitate mainly in western regions.
Captive elephants in the South also had a relatively
high antibody seroprevalence. In general, these were
working elephants from the North and West that are
taken to rest at their owner’s home in the South during
the low tourist season. Conversely, elephants in the
Central, East and Northeast regions live in more urban
areas, closer to humans, where land and especially
forest, is limited, and generally they are not exchanged
between camps. The camps in intensive management
systems also are less likely to transport elephants or re-
cruit elephants from outside those regions than those in
extensive systems. That may limit the degree of exposure
to the virus, and agrees with our finding that most ele-
phants living in isolated areas were seronegative. It is
likely the seropositive elephants that experienced recent
infection or reactivation might be related to camps with
frequent or with rare viral reactivations.
Elephants sampled in this study were involved in tour-
ism or logging, which requires tame elephants; hence, the
higher numbers of adults than other age categories, and
females being more prevalent than males. Trending to-
wards significance (OR = 1.29) was a sex effect, with more
males being seropositive, although the relevance of this is
unknown. By contrast, elephant age, camp cluster size,
and sample collection period were not significant risk fac-
tors for EEHV antibody seroprevalence. Our finding that
42.3% of captive elephants in Thailand were seropositive
for EEHV antibodies suggest a high rate of viral exposure
in this population. Extrapolating to the total captive popu-
lation in the country (n = 4016 elephants), upwards of
1600 may have been exposed to the virus. The EEHV anti-
body seroprevalence survey showed that “region” was a
significant risk factor associated with the disease inci-
dence, particularly in the North, which is likely to be re-
lated to management or perhaps genetic relationships.
Since the first diagnosed case of EEHV HD in 1999, this
disease has resulted in elephant deaths, particularly calves,
around the world, although it is more sporadic than
epidemic in captive populations. Long et al. [3] suggested
that disease severity is related to primary infection, and
that around 20% of young elephants are susceptible.
Finally, a potential limitation of the EEHV-1A gB pro-
tein antigen ELISA may be that it has insufficient sensi-
tivity to detect low antibody titers, which could lead to
an underrepresentation of seropositive animals. Van den
Doel et al. [23] suggested that one or both OD ratios
should be ≥ 3 to indicate true seropositivity, while a cut
off OD ratio ≥ 4 for both would be stricter. Hence, in
addition to the analysis presented in Table 4, we exam-
ined the distributions of positive and negative test results
in camps using cut off OD ratios of ≥ 3 respectively ≥ 4
for both dilutions (Additional file 1: Figure S1) and
found they were similar with a peak around OD ratio 2.
Both distributions showed a small elevation around OD
ratio 5 (dilution 1:100) or OD ratio 6 (dilution 1:200),
which might indicate distribution in a population with
recent reactivation of virus or recent infection, whereas
the elevation around OD ratio 2 might be the mode of
an uninfected population. Obviously a more strict defin-
ition of positive animals e.g. both OD ratios ≥ 4 could
lead to classifications of animals with low antibody titers
as EEHV-negative. Comparison of the risk factor analysis
for individual elephant data, criterion for qualification as
a positive animal “one or both OD ratios ≥3” (Table 5)
with risk factor analysis using the more stringent qualifi-
cation criterion OD ratio ≥ 4 showed the same results
(Additional file 3: Table S2). Until we are able to grow
virus in culture to establish ELISA sensitivities, there is
the risk of misinterpreting OD ratio results, either posi-
tive or negative, depending on what cutoff value is used.
Conclusions
This is the first comprehensive investigation of EEHV
antibody seroprevalence in an Asian range country. Our
study showed that 43.8% of young elephants were anti-
body seropositive, similar to the older age groups, which
suggests that elephants of all ages are being exposed to
this potentially deadly virus. Results highlight the need
for additional research to determine the immunopatho-
genesis of an EEHV infection, especially to elucidate
why antibody seroprevalence is higher in the North, and
in elephants that are more extensively managed. Gen-
omic analyses to identify potential genetic factors associ-
ated to pathogenesis also might help explain why most
elephants survive, and some do not. It is particularly
important to track elephants with EEHV antibody titers
over longer periods of time (longitudinally), especially if
they have been suspected of prior active infection.
Additional files
Additional file 1: Figure S1. Stacked bar plots with numbers of
negative and positive animals per herd (ranked on herd size). Using as
definitions for a positive sample: both OD ratio ≥ 3 (graph a) and OD
ratio ≥ 4 (graph b). (PDF 58 kb)
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Additional file 2: Table S1. Seroprevalence based on an EEHV1A
glycoprotein B protein antigen specific ELISA of elephants sampled
throughout Thailand (n = 994) between 2010 and 2015, and the
percentage of samples testing positive1, inconclusive2 or negative3
relative to potential EEHV risk factors based on different interpretation
modalities: 1:100 dilution; 1:200 dilution. (PDF 58 kb)
Additional file 3: Table S2. Univariable regression analysis of potential
risk factors for the presence of EEHV antibodies in elephants sampled
throughout Thailand between 2010 and 2015 (n = 994) based on an
EEHV1A glycoprotein B protein antigen specific ELISA. Seroprevalence is
based on strict cutoff: positive if both OD ratio’s > 4. (PDF 52 kb)
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